monoclonal antibodies

You have access
The Role of ⁸⁹Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals
Guus A.M.S. van Dongen, Wissam Beaino, Albert D. Windhorst, Gerben J.C. Zwezerijnen, Daniela E. Oprea-Lager, N. Harry Hendrikse, Cornelis van Kuijk, Ronald Boellaard, Marc C. Huisman and Danielle J. Vugts

Journal of Nuclear Medicine April 1, 2021, 62 (4) 438-445; DOI: https://doi.org/10.2967/jnumed.119.239558
You have access
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806
Hui K Gan, Matthew Burge, Benjamin Solomon, SzeTing Lee, Kyle D Holen, Yumin Zhang, Marika Ciprotti, FT Lee, Wijth Manusinghe, Judee Fischer, Peter Ansell, Gerard Fox, Hao Xiong, Edward B Reilly, Rod Humerickhouse and Andrew M Scott

Journal of Nuclear Medicine January 28, 2021, jnumed.120.253146; DOI: https://doi.org/10.2967/jnumed.120.253146
You have access
Comparison of CD38 targeted alpha- vs beta-radionuclide therapy of disseminated multiple myeloma in an animal model
Megan Minnix, Vikram Adhikarla, Enrico Caserta, Erasmus Poku, Russell Rockne, John E Shively and Flavia Pichiorri

Journal of Nuclear Medicine October 30, 2020, jnumed.120.251983; DOI: https://doi.org/10.2967/jnumed.120.251983
You have access
Photoacoustic Molecular Imaging for the Identification of Lymph Node Metastasis in Head and Neck Cancer using an anti-EGFR Antibody-Dye Conjugate
Naoki Nishio, Nynke S. van den Berg, Brock A Martin, Stan van Keulen, Shayan Fakurnejad, Eben L Rosenthal and Katheryne E Wilson

Journal of Nuclear Medicine October 2, 2020, jnumed.120.245241; DOI: https://doi.org/10.2967/jnumed.120.245241
You have access
⁸⁹Zr Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression
Kyung-Ho Jung, Jin Won Park, Jin Hee Lee, Eun Ji Lee, Seung Hwan Moon, Young Seok Cho and Kyung-Han Lee

Journal of Nuclear Medicine September 11, 2020, jnumed.120.250720; DOI: https://doi.org/10.2967/jnumed.120.250720
You have access
⁸⁹Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo
Yvonne W.S. Jauw, Joseph A. O’Donoghue, Josée M. Zijlstra, Otto S. Hoekstra, C. Willemien Menke-van der Houven van Oordt, Franck Morschhauser, Jorge A. Carrasquillo, Sonja Zweegman, Neeta Pandit-Taskar, Adriaan A. Lammertsma, Guus. A.M.S. van Dongen, Ronald Boellaard, Wolfgang A. Weber and Marc C. Huisman

Journal of Nuclear Medicine December 1, 2019, 60 (12) 1825-1832; DOI: https://doi.org/10.2967/jnumed.118.224568
Open Access
Synergistic Effect of a Mesothelin-Targeted ²²⁷Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models
Katrine Wickstroem, Urs B. Hagemann, Véronique Cruciani, Antje M. Wengner, Alexander Kristian, Christine Ellingsen, Gerhard Siemeister, Roger M. Bjerke, Jenny Karlsson, Olav B. Ryan, Lars Linden, Dominik Mumberg, Karl Ziegelbauer and Alan S. Cuthbertson

Journal of Nuclear Medicine September 1, 2019, 60 (9) 1293-1300; DOI: https://doi.org/10.2967/jnumed.118.223701
You have access
Theranostics Using Antibodies and Antibody-Related Therapeutics
Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de Vries

Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
You have access
Development of ¹²⁴I Immuno-PET Targeting Tumor Vascular TEM1/Endosialin
Ann-Marie Chacko, Chunsheng Li, Madhura Nayak, John L. Mikitsh, Jia Hu, Catherine Hou, Luigi Grasso, Nicholas C. Nicolaides, Vladimir R. Muzykantov, Chaitanya R. Divgi and George Coukos

Journal of Nuclear Medicine March 1, 2014, 55 (3) 500-507; DOI: https://doi.org/10.2967/jnumed.113.121905

Main menu

User menu

Search

monoclonal antibodies